Key Financial Data Of Group

OncoTherapy Science, Inc. - Filing #7329199

Concept 2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
Key financial data of group
Business results of group
Ordinary profit (loss)
-873,356,000 JPY
-1,136,373,000 JPY
-1,086,234,000 JPY
-1,133,099,000 JPY
-2,011,350,000 JPY
-2,071,783,000 JPY
-1,336,660,000 JPY
-1,639,262,000 JPY
-1,790,856,000 JPY
-2,197,193,000 JPY
Profit (loss) attributable to owners of parent
-1,288,138,000 JPY
-1,118,644,000 JPY
-2,571,541,000 JPY
-1,561,636,000 JPY
-2,238,558,000 JPY
Comprehensive income
-1,288,138,000 JPY
-1,118,644,000 JPY
-2,571,541,000 JPY
-1,561,636,000 JPY
-2,228,502,000 JPY
Net assets
353,666,000 JPY
353,666,000 JPY
574,812,000 JPY
855,169,000 JPY
1,980,233,000 JPY
1,698,410,000 JPY
3,076,822,000 JPY
2,649,689,000 JPY
4,728,481,000 JPY
4,286,733,000 JPY
Total assets
867,275,000 JPY
507,227,000 JPY
949,263,000 JPY
1,511,438,000 JPY
2,685,199,000 JPY
2,116,549,000 JPY
3,368,102,000 JPY
2,894,992,000 JPY
5,088,076,000 JPY
4,616,437,000 JPY
Net assets per share
1.28
1.28
2.58
4.04
9.84
8.38
16.96
14.53
25.81
23.31
Basic earnings (loss) per share
-4.74
-6.05
-5.80
-5.81
-12.94
-13.72
-8.77
-8.86
-12.13
-13.73
Diluted earnings per share
Equity-to-asset ratio
0.322 xbrli:pure
0.550 xbrli:pure
0.524 xbrli:pure
0.515 xbrli:pure
0.706 xbrli:pure
0.763 xbrli:pure
0.888 xbrli:pure
0.885 xbrli:pure
0.895 xbrli:pure
0.890 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-1,227,990,000 JPY
-794,901,000 JPY
-2,073,224,000 JPY
-1,762,629,000 JPY
-2,275,529,000 JPY
Net cash provided by (used in) investing activities
-33,354,000 JPY
-20,319,000 JPY
-467,928,000 JPY
-52,225,000 JPY
-30,700,000 JPY
Net cash provided by (used in) financing activities
671,365,000 JPY
95,950,000 JPY
1,478,967,000 JPY
JPY
2,164,089,000 JPY
Cash and cash equivalents
527,656,000 JPY
1,117,635,000 JPY
1,836,906,000 JPY
2,899,092,000 JPY
4,713,947,000 JPY
Number of employees
xbrli:pure
54 xbrli:pure
27 xbrli:pure
27 xbrli:pure
27 xbrli:pure
27 xbrli:pure
28 xbrli:pure
60 xbrli:pure
67 xbrli:pure
36 xbrli:pure
66 xbrli:pure
35 xbrli:pure
62 xbrli:pure
32 xbrli:pure
Average number of temporary employees
xbrli:pure
4 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
4 xbrli:pure
1 xbrli:pure
7 xbrli:pure
6 xbrli:pure
1 xbrli:pure
5 xbrli:pure
3 xbrli:pure
9 xbrli:pure
6 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.